|
1
|
Oosterhuis JW, Stoop H, Honecker F and
Looijenga LH: Why human extragonadal germ cell tumours occur in the
midline of the body: old concepts, new perspectives. Int J Androl.
30:256–263. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kuyumcuoğlu U and Kale A: Unusual
presentation of a dermoid cyst that derived from the bladder dome
presenting as subserosal leiomyoma uteri. Clin Exp Obstet Gynecol.
35:309–310. 2008.
|
|
3
|
Taylor G, Jordan M, Churchill B and Mancer
K: Yolk sac tumor of the bladder. J Urol. 129:591–594.
1983.PubMed/NCBI
|
|
4
|
Tinkler SD, Roberts JT, Robinson MC and
Ramsden PD: Primary choriocarcinoma of the urinary bladder: a case
report. Clin Oncol (R Coll Radiol). 8:59–61. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fowler AL, Hall E and Rees G:
Choriocarcinoma arising in transitional cell carcinoma of the
bladder. Br J Urol. 70:333–334. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yokoyama S, Hayashida Y, Nagahama J,
Nakayama I, Kashima K and Ogata J: Primary and metaplastic
choriocarcinoma of the bladder. A report of two cases. Acta Cytol.
36:176–182. 1992.PubMed/NCBI
|
|
7
|
Huang HY, Ko SF, Chuang JH, Jeng YM, Sung
MT and Chen WJ: Primary yolk sac tumor of the urachus. Arch Pathol
Lab Med. 126:1106–1109. 2002.PubMed/NCBI
|
|
8
|
Bokemeyer C, Hartmann JT, Fossa SD, et al:
Extragonadal germ cell tumors: relation to testicular neoplasia and
management options. APMIS. 111:49–63. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ait Benali H, Lalya L, Allaoui M, et al:
Extragonadal mixed germ cell tumor of the right arm: description of
the first case in the literature. World J Surg Oncol.
10:692012.PubMed/NCBI
|
|
10
|
Furtado LV, Leventaki V, Layfield LJ,
Lowichik A, Muntz HR and Pysher TJ: Yolk sac tumor of the thyroid
gland: a case report. Pediatr Dev Pathol. 14:475–479. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim SW, Park JH, Lim MC, Park JY, Yoo CW
and Park SY: Primary yolk sac tumor of the omentum: a case report
and review of the literature. Arch Gynecol Obstet. 279:189–192.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pasternack T, Shaco-Levy R, Wiznitzer A
and Piura B: Extraovarian pelvic yolk sac tumor: case report and
review of published work. J Obstet Gynaecol Res. 34:739–744. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dede M, Pabuccu R, Yagci G, Yenen MC,
Goktolga U and Gunhan O: Extragonadal yolk sac tumor in pelvic
localization. A case report and literature review. Gynecol Oncol.
92:989–991. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Moran CA, Suster S and Koss MN: Primary
germ cell tumors of the mediastinum: III. Yolk sac tumor, embryonal
carcinoma, choriocarcinoma and combined nonteratomatous germ cell
tumors of the mediastinum - a clinicopathologic and
immunohistochemical study of 64 cases. Cancer. 80:699–707. 1997.
View Article : Google Scholar
|
|
15
|
Hoei-Hansen CE, Kraggerud SM, Abeler VM,
Kaern J, Rajpert-De Meyts E and Lothe RA: Ovarian dysgerminomas are
characterised by frequent KIT mutations and abundant expression of
pluripotency markers. Mol Cancer. 6:122007. View Article : Google Scholar
|
|
16
|
Cao D, Humphrey PA and Allan RW: SALL4 is
a novel sensitive and specific marker for metastatic germ cell
tumors, with particular utility in detection of metastatic yolk sac
tumors. Cancer. 115:2640–2651. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gupta R, Mathur SR, Arora VK and Sharma
SG: Cytologic features of extragonadal germ cell tumors: a study of
88 cases with aspiration cytology. Cancer. 114:504–511. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang F, Liu A, Peng Y, et al: Diagnostic
utility of SALL4 in extragonadal yolk sac tumors: an
immunohistochemical study of 59 cases with comparison to
placental-like alkaline phosphatase, alpha-fetoprotein and
glypican-3. Am J Surg Pathol. 33:1529–1539. 2009. View Article : Google Scholar
|
|
19
|
Venyo A and Benatar B: A Review of the
Literature on Ketamine-Abuse-Uropathy. WebmedCentral Urology.
3:WMC0030482012.
|
|
20
|
Chu PS, Kwok SC, Lam KM, et al: ‘Street
ketamine’-associated bladder dysfunction: a report of ten cases.
Hong Kong Med J. 13:311–313. 2007.
|
|
21
|
Shahani R, Streutker C, Dickson B and
Stewart RJ: Ketamine associated ulcerative cystitis: a new clinical
entity. Urology. 69:810–812. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Itano NM and Malek RS: Eosinophil cystitis
in adults. J Urol. 165:805–807. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
No authors listed. International Germ Cell
Consensus Classification: a prognostic factor-based staging system
for metastatic germ cell cancers. International Germ Cell Cancer
Collaborative Group. J Clin Oncol. 15:594–603. 1997.PubMed/NCBI
|
|
24
|
Bokemeyer C, Nichols CR, Droz JP, et al:
Extragonadal germ cell tumors of the mediastinum and
retroperitoneum: results from an international analysis. J Clin
Oncol. 20:1864–1873. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
De Corti F, Sarnacki S, Pattec C, et al:
Prognosis of malignant sacrococcygeal germ cell tumours according
to their natural history and surgical management. Surg Oncol.
21:e31–e37. 2012.PubMed/NCBI
|
|
26
|
Pliarchopoulou K and Pectasides D:
First-line chemotherapy of non-seminomatous germ cell tumors
(NSGCTs). Cancer Treat Rev. 35:563–569. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
de La Motte Rouge T, Pautier P, Duvillard
P, et al: Survival and reproductive function of 52 women treated
with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy
for ovarian yolk sac tumor. Ann Oncol. 19:1435–1441.
2008.PubMed/NCBI
|
|
28
|
Riese MJ and Vaughn DJ: Chemotherapy for
patients with poor prognosis germ cell tumors. World J Urol.
27:471–476. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hartmann JT, Nichols CR, Droz JP, et al:
Prognostic variables for response and outcome in patients with
extragonadal germ-cell tumors. Ann Oncol. 13:1017–1028. 2002.
View Article : Google Scholar : PubMed/NCBI
|
